ISG Business School

NaaS Technology Inc. Reports Unaudited 2023 Fourth Quarter and Full Year Financial Results

Retrieved on: 
Thursday, March 28, 2024
Research, EV, PIN, Head, Growth, H.10, RMB, NTR, GTR, Great Wall Motor, Transport, ISG Business School, Translation, Bank statement, Network as a service, Engineering, Energy, Ecosystem, Digital technology, University of Oxford, USD, Marketing, Toyota Group, Economics, Video game

2023 Fourth Quarter Financial Results:

Key Points: 
  • 2023 Fourth Quarter Financial Results:
    Total revenues reached RMB64.4 million (US$9.1 million) for the fourth quarter of 2023, representing an increase of 119% year over year.
  • Total cost of revenues increased 114% from RMB22.3 million for the fourth quarter of 2022 to RMB47.7 million (US$6.7 million) for the fourth quarter of 2023.
  • Total operating expenses increased from RMB128.8 million for the fourth quarter of 2022 to RMB415.5 million (US$58.5 million) for the fourth quarter of 2023.
  • Net margin decreased from negative 431% for the fourth quarter of 2022 to negative 770% for the fourth quarter of 2023 and non-IFRS net margin decreased from negative 380% for the fourth quarter of 2022 to negative 494% for the fourth quarter of 2023.

Preeclampsia Foundation Announces New 2024 Leadership of Board of Directors

Retrieved on: 
Monday, January 29, 2024
CTP, Pre-eclampsia, RNC, MMM, JD, Organization, MPH, Communication, Mother, Women's health, Master, Senate, DeBevoise, Medical director, Martha Plimpton, ISG Business School, MPPA, Mortality, AWHONN, MBA, CFP, Marketing, Security (finance), Justice, Certified Treasury Professional, Internal bleeding, Certified Public Accountant, Nursing credentials and certifications, APN, CPE, Merck, Management

MELBOURNE, Fla., Jan. 29, 2024 /PRNewswire/ -- The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors today.

Key Points: 
  • MELBOURNE, Fla., Jan. 29, 2024 /PRNewswire/ -- The Preeclampsia Foundation welcomed a new group of officers to their 2024 Board of Directors today.
  • "We continue to be honored and grateful for the professional leadership provided by the officers and members of our Board of Directors," said Preeclampsia Foundation CEO Eleni Tsigas.
  • Treasurer Raphaël Charbit joined the Preeclampsia Foundation board of directors in 2023, bringing his vast financial management expertise to the team.
  • The Foundation also expresses its deep gratitude to immediate past chair, Dr. Rakhi Dimino, for her leadership and guidance on the Board of Directors.